The glioma microenvironment secretes a variety of immunosuppressive factors, such as TGF-β2, prostaglandin E2 (PGE2), IL-1, IL-10 and fibrinogen-like protein 2 (FGL2). This evidence concerns the gene FGL2 and central nervous system cancer.